344 material Form 8-K filings that 303 companies we cover made with the SEC in August 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
e.l.f. Beauty's board authorized a new share repurchase program of up to $500 million of common stock, replacing a $25 million program from 2019 that has been exhausted. The company also amended its credit agreement to increase capacity for restricted payments, such as share repurchases, subject to a pro forma net leverage ratio test. Shareholders also elected three Class II directors and approved officer exculpation and executive compensation at the August 22, 2024 annual meeting.
New share repurchase program authorizes up to $500 million of common stock, with no expiration date and no required minimum purchases.
Prior $25 million program, announced in May 2019, is exhausted after about $17 million in repurchases over the past two weeks.
Third Amendment to the credit agreement, dated August 26, 2024, raises restricted payment capacity subject to a pro forma net leverage ratio test.
At the August 22, 2024 annual meeting, shareholders approved officer exculpation (37,234,458 for) and advisory executive compensation (40,676,556 for).
UFP Industries said its board appointed William D. Schwartz as chief executive officer effective December 29, 2024, and named current CEO Matthew J. Missad as executive chairman on the same date. The changes are a planned succession, and Missad has agreed to serve as executive chairman through 2026. The filing discloses pay changes for both men but no changes to reported financial results.
William D. Schwartz, currently president of UFP Retail, will become CEO on December 29, 2024, with base salary rising to $600,000 per year
Matthew J. Missad, CEO since July 2011, becomes executive chairman on December 29, 2024, at a base salary of $500,000 per year
Missad has agreed to remain executive chairman through 2026 and will assist with shareholder relations
CFO Michael Cole will add the title of President of Corporate Services
Arcus Biosciences entered a Loan and Security Agreement with Hercules Capital on August 27, 2024, providing a secured term loan facility of up to $250.0 million. Only $50.0 million was funded at closing, with the rest available under later tranches at the company's option or the lenders' option, and the loans are secured by substantially all company assets.
$50.0 million funded on August 27, 2024; up to $150.0 million more available at the company's option through March 15, 2026, and a further $100.0 million at the lenders' option
Interest at the greater of Prime Rate plus 1.95% or 10.45%; interest-only payments until September 1, 2028; maturity September 1, 2029
Financial covenant requires Qualified Cash of at least 50% of outstanding principal when market capitalization is at or below $1.20 billion, with reductions upon milestones
Insperity's longtime chief financial officer, Douglas S. Sharp, will retire on November 15, 2024, after 21 years in the role. James D. Allison, currently executive vice president of comprehensive benefit solutions and chief profitability officer, will succeed him as CFO on the same date, and Sean P. Duffy will be promoted to senior vice president of finance and accounting.
Douglas S. Sharp retires as CFO effective November 15, 2024, after serving as CFO for 21 years
James D. Allison, who joined Insperity in 1997, becomes executive vice president of finance, CFO and treasurer on November 15, 2024, with his annual salary increased to $550,000
Sean P. Duffy is promoted to senior vice president of finance and accounting, with a salary of $375,000 and a special award of 5,100 restricted stock units vesting in annual thirds
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.